Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.

Medicine - 12 Mar 2021

Liu Zaoqu, Jiao Dechao, Liu Long, Zhou Xueliang, Yao Yuan, Li Zhaonan, Li Jing, Chen Jianjian, Lei Qinyu, Han Xinwei

Abstract excerpt

BACKGROUND: Increasing evidence has indicated immune-related genes (IRGs) play a key role in the development of hepatocellular carcinoma (HCC). Whereas, there have been no investigations proposing a reliable prognostic signature in terms of IRGs. This study aimed to develop a robust signature based on IRGs in HCC. A total of 597 HCC patients from The Cancer Genome Atlas (TCGA) and International Cancer Genome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Liver Neoplasms

Share to Nomograms

Share to Prognosis

Share to Risk Assessment

Share to Tumor Burden

Source

Open in PubMed Open full text

Identifiers

PMID: 33725827
DOI: 10.1097/MD.0000000000024683
PMCID: PMC7969274

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.PMID 33725827Read ↗

Development and validation of a robust immune-related risk signature for hepatocellular carcinomaSemantic proximity Read ↗

A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltrationSemantic proximity Read ↗

Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.Semantic proximity Read ↗

Identification and validation of an immune-related prognostic signature for hepatocellular carcinomaSemantic proximity Read ↗

Development and validation of a novel immune-related prognostic model in hepatocellular carcinomaSemantic proximity Read ↗

Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8+ T Cell InfiltrationSemantic proximity Read ↗

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signatureSemantic proximity Read ↗

A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.Semantic proximity Read ↗

Immunogenic Cell Death Genes Related Prognostic Biomarker in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification and Analysis of Immune-Related Gene Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

An immunogenic cell death-associated gene signature predicts prognosis in hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.